AI-generated summary
The authors followed 77 patients with severe, medication-resistant angina for a mean of 3 years after percutaneous myocardial laser therapy, extending earlier 1-year trial results. They report that angina class improved from baseline at 1 year and at late follow-up, and that nitrate use decreased, while ejection fraction did not change. The study was a longitudinal follow-up without a concurrent control group reported in the abstract.
- Participants
- 77
- Who or what was studied
- Patients with chronic, stable, medically refractory angina (class III or IV) not amenable to conventional revascularization, with evidence of reversible ischemia, ejection fraction of 25% or higher, and myocardial wall thickness of 8 mm or more
- Limits stated in the abstract
- The abstract reports a single-arm longitudinal follow-up of a modest sample without a control group for the late period, and it does not describe the late-stage design in detail.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.